GB2368014B - Pharmaceutical composition containing citalopram - Google Patents

Pharmaceutical composition containing citalopram

Info

Publication number
GB2368014B
GB2368014B GB0118579A GB0118579A GB2368014B GB 2368014 B GB2368014 B GB 2368014B GB 0118579 A GB0118579 A GB 0118579A GB 0118579 A GB0118579 A GB 0118579A GB 2368014 B GB2368014 B GB 2368014B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
composition containing
containing citalopram
citalopram
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0118579A
Other languages
English (en)
Other versions
GB2368014A (en
GB0118579D0 (en
Inventor
Per Holm
Ken Liljegren
Ole Nielsen
Swen Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB2368014(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Priority to GB0219820A priority Critical patent/GB2376233B/en
Publication of GB0118579D0 publication Critical patent/GB0118579D0/en
Publication of GB2368014A publication Critical patent/GB2368014A/en
Application granted granted Critical
Publication of GB2368014B publication Critical patent/GB2368014B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0118579A 2000-08-10 2001-07-31 Pharmaceutical composition containing citalopram Expired - Fee Related GB2368014B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0219820A GB2376233B (en) 2000-08-10 2001-07-31 Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (3)

Publication Number Publication Date
GB0118579D0 GB0118579D0 (en) 2001-09-19
GB2368014A GB2368014A (en) 2002-04-24
GB2368014B true GB2368014B (en) 2004-06-23

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0118579A Expired - Fee Related GB2368014B (en) 2000-08-10 2001-07-31 Pharmaceutical composition containing citalopram

Country Status (34)

Country Link
EP (1) EP1318805A2 (ja)
JP (1) JP2003531153A (ja)
KR (1) KR20030024833A (ja)
CN (1) CN1446089A (ja)
AR (1) AR030095A1 (ja)
AT (1) AT5744U1 (ja)
AU (2) AU2001100198B4 (ja)
BE (1) BE1013559A6 (ja)
BG (1) BG107578A (ja)
BR (1) BR0113250A (ja)
CA (1) CA2353693C (ja)
CH (2) CH694241A5 (ja)
CZ (1) CZ2003397A3 (ja)
DE (2) DE10139115A1 (ja)
EA (1) EA200300247A1 (ja)
ES (1) ES2172481B2 (ja)
FI (1) FI5176U1 (ja)
FR (1) FR2812811B1 (ja)
GB (1) GB2368014B (ja)
GR (1) GR1004193B (ja)
HR (1) HRP20030054A2 (ja)
HU (1) HUP0103071A3 (ja)
IE (1) IES20010693A2 (ja)
IL (1) IL154050A0 (ja)
IS (1) IS6021A (ja)
IT (1) ITMI20011637A1 (ja)
MX (1) MXPA03000837A (ja)
NL (1) NL1018741C1 (ja)
NO (1) NO20013891L (ja)
NZ (1) NZ523785A (ja)
PL (1) PL359824A1 (ja)
SK (1) SK2842003A3 (ja)
WO (1) WO2001080619A2 (ja)
YU (1) YU9003A (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
PT1578738E (pt) * 2002-12-23 2008-04-11 Lundbeck & Co As H Bromidrato de escitalopram e um método para a sua preparação
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2480192A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
WO2017020841A1 (zh) * 2015-08-03 2017-02-09 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
US20240100012A1 (en) * 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form
WO2024165628A1 (en) 2023-02-07 2024-08-15 Kinast Lasse An immediate-release oral pharmaceutical form of escitalopram or racemate thereof with increased api content

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136193A (en) * 1976-01-14 1979-01-23 Kefalas A/S Anti-depressive substituted 1-dimethylaminopropyl-1-phenyl phthalans
EP0171943A1 (en) * 1984-08-06 1986-02-19 H. Lundbeck A/S Novel intermediate and method for its preparation
EP0347066A1 (en) * 1988-06-14 1989-12-20 H. Lundbeck A/S New enantiomers and their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A2 (en) * 1994-11-28 1996-06-05 Eli Lilly And Company Potentiation of drug response by a serotonin 1A receptor antagonist
GB2357762A (en) * 2000-03-13 2001-07-04 Lundbeck & Co As H Preparation of Crystalline Base or Salts of Citalopram
EP1152000A1 (en) * 2000-05-02 2001-11-07 SUMIKA FINE CHEMICALS Co., Ltd. Citalopram hydrobromide crystal and method for crystallization thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136193A (en) * 1976-01-14 1979-01-23 Kefalas A/S Anti-depressive substituted 1-dimethylaminopropyl-1-phenyl phthalans
EP0171943A1 (en) * 1984-08-06 1986-02-19 H. Lundbeck A/S Novel intermediate and method for its preparation
EP0347066A1 (en) * 1988-06-14 1989-12-20 H. Lundbeck A/S New enantiomers and their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A2 (en) * 1994-11-28 1996-06-05 Eli Lilly And Company Potentiation of drug response by a serotonin 1A receptor antagonist
GB2357762A (en) * 2000-03-13 2001-07-04 Lundbeck & Co As H Preparation of Crystalline Base or Salts of Citalopram
EP1152000A1 (en) * 2000-05-02 2001-11-07 SUMIKA FINE CHEMICALS Co., Ltd. Citalopram hydrobromide crystal and method for crystallization thereof

Also Published As

Publication number Publication date
ES2172481B2 (es) 2004-08-01
GB2368014A (en) 2002-04-24
HUP0103071A3 (en) 2002-12-28
EA200300247A1 (ru) 2003-06-26
FR2812811A1 (fr) 2002-02-15
HRP20030054A2 (en) 2005-02-28
GR20010100377A (el) 2002-09-06
MXPA03000837A (es) 2003-06-06
NL1018741C1 (nl) 2002-02-12
JP2003531153A (ja) 2003-10-21
IES20010693A2 (en) 2002-07-10
CZ2003397A3 (cs) 2003-06-18
WO2001080619A2 (en) 2001-11-01
SK2842003A3 (en) 2003-09-11
DE20113195U1 (de) 2001-11-15
BG107578A (bg) 2003-09-30
HU0103071D0 (en) 2001-10-28
EP1318805A2 (en) 2003-06-18
KR20030024833A (ko) 2003-03-26
BE1013559A6 (fr) 2002-03-05
YU9003A (sh) 2006-05-25
FI5176U1 (fi) 2001-12-27
PL359824A1 (en) 2004-09-06
AU2001100198B4 (en) 2002-06-13
CN1446089A (zh) 2003-10-01
ITMI20011637A1 (it) 2003-01-27
BR0113250A (pt) 2003-06-24
IL154050A0 (en) 2003-07-31
CA2353693C (en) 2003-07-22
CH694242A5 (de) 2004-10-15
AU2001100198A4 (en) 2001-08-16
IS6021A (is) 2001-10-20
ES2172481A1 (es) 2002-09-16
HUP0103071A2 (hu) 2002-05-29
CA2353693A1 (en) 2002-01-22
WO2001080619A3 (en) 2002-02-21
DE10139115A1 (de) 2002-03-28
ITMI20011637A0 (it) 2001-07-27
NO20013891L (no) 2002-02-11
CH694241A5 (de) 2004-10-15
AU2001279591A1 (en) 2001-11-07
GR1004193B (el) 2003-03-24
NO20013891D0 (no) 2001-08-09
AR030095A1 (es) 2003-08-13
AT5744U1 (de) 2002-11-25
FR2812811B1 (fr) 2006-08-18
NZ523785A (en) 2004-09-24
GB0118579D0 (en) 2001-09-19

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
HUP0204555A3 (en) Pharmaceutical composition
GB0001621D0 (en) Pharmaceutical compositions
AU6219601A (en) Pharmaceutical compositions
AU8576801A (en) Pharmaceutical compositions
HK1057474A1 (en) Medicinal composition
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
GB2368014B (en) Pharmaceutical composition containing citalopram
IL154238A0 (en) Pharmaceutical composition
GB0008485D0 (en) Pharmaceutical compositions
HRP20030546A2 (en) Pharmaceutical composition containing citalopram
GB0005382D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
GB0101094D0 (en) Pharmaceutical composition
GB0016684D0 (en) Pharmaceutical composition
GB0026716D0 (en) Pharmaceutical composition
GB0027375D0 (en) Pharmaceutical composition
GB0006301D0 (en) Pharmaceutical composition
GB0019599D0 (en) Pharmaceutical composition
GB0219820D0 (en) Pharmaceutical compostion containing citalopram
DK200100203U4 (da) Farmaceutisk komposition indeholdende citalopram
HU0000060D0 (en) Novel pharmaceutical compositions
GB0003929D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20080731